Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis.

Naidoo A, Chirehwa M, Ramsuran V, McIlleron H, Naidoo K, Yende-Zuma N, Singh R, Ncgapu S, Adamson J, Govender K, Denti P, Padayatchi N.

Pharmacogenomics. 2019 Feb 15. doi: 10.2217/pgs-2018-0166. [Epub ahead of print]

PMID:
30767706
2.

Arylacetamide deacetylase (AADAC) gene polymorphism and HIV infection affect the exposure of Rifapentine: a population pharmacokinetics analysis.

Francis J, Zvada SP, Denti P, Hatherill M, Charalambous S, Mungofa S, Dawson R, Dorman S, Gupte N, Wiesner L, Jindani A, Harrison TS, Olagunju A, Egan D, Owen A, McIlleron HM.

Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01964-18. doi: 10.1128/AAC.01964-18. [Epub ahead of print]

3.

Pharmacokinetics, safety, and dosing of novel pediatric levofloxacin dispersible tablets in children with multidrug-resistant tuberculosis exposure.

Garcia-Prats AJ, Purchase SE, Osman M, Draper HR, Schaaf HS, Wiesner L, Denti P, Hesseling AC.

Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01865-18. doi: 10.1128/AAC.01865-18. [Epub ahead of print]

PMID:
30670421
4.

The Tricuspid Valve Relationship With the Right Ventricle and Pulmonary Vasculature.

Hahn RT, Delhaas T, Denti P, Waxman AB.

JACC Cardiovasc Imaging. 2019 Jan 9. pii: S1936-878X(18)31086-6. doi: 10.1016/j.jcmg.2018.11.016. [Epub ahead of print] No abstract available.

PMID:
30660539
5.

Chiral optical tweezers for optically active particles in the T-matrix formalism.

Patti F, Saija R, Denti P, Pellegrini G, Biagioni P, Iatì MA, Maragò OM.

Sci Rep. 2019 Jan 10;9(1):29. doi: 10.1038/s41598-018-36434-9.

6.

Linezolid pharmacokinetics in South African patients with drug resistant tuberculosis and a high prevalence of HIV co-infection.

Wasserman S, Denti P, Brust JCM, Tareq M, Hlungulu S, Wiesner L, Norman J, Sirgel FA, Warren RM, Esmail A, Dheda K, Gandhi NR, Meintjes G, Maartens G.

Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.02164-18. doi: 10.1128/AAC.02164-18. [Epub ahead of print]

PMID:
30617089
7.

Outcomes After Current Transcatheter Tricuspid Valve Intervention: Mid-Term Results From the International TriValve Registry.

Taramasso M, Alessandrini H, Latib A, Asami M, Attinger-Toller A, Biasco L, Braun D, Brochet E, Connelly KA, Denti P, Deuschl F, Englmeier A, Fam N, Frerker C, Hausleiter J, Himbert D, Ho E, Juliard JM, Kaple R, Kreidel F, Kuck KH, Ancona M, Lauten A, Lurz P, Mehr M, Nazif T, Nickening G, Pedrazzini G, Pozzoli A, Praz F, Puri R, Rodés-Cabau J, Schäfer U, Schofer J, Sievert H, Sievert K, Tang GHL, Tanner FC, Vahanian A, Webb JG, Windecker S, Yzeiray E, Zuber M, Maisano F, Leon MB, Hahn RT.

JACC Cardiovasc Interv. 2019 Jan 28;12(2):155-165. doi: 10.1016/j.jcin.2018.10.022. Epub 2018 Dec 26.

PMID:
30594510
8.

Mid-term outcomes (up to 5 years) of percutaneous edge-to-edge mitral repair in the real-world according to regurgitation mechanism: A single-center experience.

Buzzatti N, Denti P, Scarfò IS, Giambuzzi I, Schiavi D, Ruggeri S, Castiglioni A, De Bonis M, La Canna G, Alfieri O.

Catheter Cardiovasc Interv. 2018 Dec 27. doi: 10.1002/ccd.28029. [Epub ahead of print]

PMID:
30592134
9.

Anesthesiologic Management of Patients Undergoing Cardiac Transapical Procedures: Which Challenges in the Modern Era?

Pieri M, De Luca M, Gerli C, Crivellari M, Buzzatti N, Denti P, Stamelos M, Zangrillo A, Landoni G, Monaco F.

J Cardiothorac Vasc Anesth. 2018 Oct 28. pii: S1053-0770(18)31011-5. doi: 10.1053/j.jvca.2018.10.039. [Epub ahead of print]

PMID:
30581110
10.

Lopinavir-ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir-ritonavir without rifampicin: a pharmacokinetic modelling and clinical study.

Rabie H, Denti P, Lee J, Masango M, Coovadia A, Pillay S, Liberty A, Simon F, McIlleron H, Cotton MF, Lallemant M.

Lancet HIV. 2018 Dec 6. pii: S2352-3018(18)30293-5. doi: 10.1016/S2352-3018(18)30293-5. [Epub ahead of print]

PMID:
30529029
11.

Transcatheter Tricuspid Valve Repair With a Novel Cinching System.

Gheorghe L, Swaans M, Denti P, Rensing B, Van der Heyden J.

JACC Cardiovasc Interv. 2018 Dec 24;11(24):e199-e201. doi: 10.1016/j.jcin.2018.09.019. Epub 2018 Nov 28. No abstract available.

PMID:
30503598
12.

Transcatheter Repair of Severe Functional Tricuspid Insufficiency Using Mitraclip System: Transgastric Views Are the Key for an Effective Guide.

Faletra FF, Pedrazzini G, Züber M, Leo LA, Paiocchi V, Maisano F, Denti P, Moccetti T.

JACC Cardiovasc Imaging. 2018 Nov 8. pii: S1936-878X(18)30838-6. doi: 10.1016/j.jcmg.2018.09.010. [Epub ahead of print] No abstract available.

PMID:
30448138
13.

A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs.

Daskapan A, Idrus LR, Postma MJ, Wilffert B, Kosterink JGW, Stienstra Y, Touw DJ, Andersen AB, Bekker A, Denti P, Hemanth Kumar AK, Jeremiah K, Kwara A, McIlleron H, Meintjes G, van Oosterhout JJ, Ramachandran G, Rockwood N, Wilkinson RJ, van der Werf TS, Alffenaar JC.

Clin Pharmacokinet. 2018 Nov 8. doi: 10.1007/s40262-018-0716-8. [Epub ahead of print] Review.

14.

Erratum for Brunschwig et al., "UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria".

Brunschwig C, Lawrence N, Taylor D, Abay E, Njoroge M, Basarab GS, Le Manach C, Paquet T, Gonzàlez Cabrera D, Nchinda AT, de Kock C, Wiesner L, Denti P, Waterson D, Blasco B, Leroy D, Witty MJ, Donini C, Duffy J, Wittlin S, White KL, Charman SA, Jiménez-Díaz MB, Angulo-Barturen I, Herreros E, Gamo FJ, Rochford R, Mancama D, Coetzer TL, van der Watt ME, Reader J, Birkholtz LM, Marsh KC, Solapure SM, Burke JE, McPhail JA, Vanaerschot M, Fidock DA, Fish PV, Siegl P, Smith DA, Wirjanata G, Noviyanti R, Price RN, Marfurt J, Silue KD, Street LJ, Chibale K.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01941-18. doi: 10.1128/AAC.01941-18. Print 2018 Nov. No abstract available.

15.

Transcatheter Mitral Valve Replacement in Patients With Previous Aortic Valve Replacement.

Cheung A, Webb J, Schaefer U, Moss R, Deuschl FG, Conradi L, Denti P, Latib A, Kiaii B, Bagur R, Ferrari E, Moccetti M, Biasco L, Blanke P, Ben-Gal Y, Banai S.

Circ Cardiovasc Interv. 2018 Oct;11(10):e006412. doi: 10.1161/CIRCINTERVENTIONS.118.006412.

PMID:
30354628
16.

The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countries.

Pillai G, Chibale K, Constable EC, Keller AN, Gutierrez MM, Mirza F, Sengstag C, Masimirembwa C, Denti P, Maartens G, Ramsay M, Ogutu B, Makonnen E, Gordon R, Ferreira CG, Goldbaum FA, Degrave WMS, Spector J, Tadmor B, Kaiser HJ.

BMC Med Educ. 2018 Oct 10;18(1):233. doi: 10.1186/s12909-018-1331-y.

17.

Effect of efavirenz-based antiretroviral therapy and high-dose rifampicin on the pharmacokinetics of isoniazid and acetyl-isoniazid.

Chirehwa MT, McIlleron H, Wiesner L, Affolabi D, Bah-Sow O, Merle C, Denti P; RAFA team .

J Antimicrob Chemother. 2019 Jan 1;74(1):139-148. doi: 10.1093/jac/dky378.

PMID:
30239829
18.

Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing.

Innes S, van der Laan L, Anderson PL, Cotton M, Denti P.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e00761-18. doi: 10.1128/AAC.00761-18. Print 2018 Nov.

19.

MitraClip for radiotherapy-related mitral valve regurgitation.

Scarfò I, Denti P, Citro R, Buzzatti N, Alfieri O, La Canna G.

Hellenic J Cardiol. 2018 Jul 26. pii: S1109-9666(18)30237-9. doi: 10.1016/j.hjc.2018.07.006. [Epub ahead of print]

20.

Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing.

Ali AM, Penny MA, Smith TA, Workman L, Sasi P, Adjei GO, Aweeka F, Kiechel JR, Jullien V, Rijken MJ, McGready R, Mwesigwa J, Kristensen K, Stepniewska K, Tarning J, Barnes KI, Denti P; WWARN Amodiaquine PK Study Group .

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e02193-17. doi: 10.1128/AAC.02193-17. Print 2018 Oct.

21.

UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria.

Brunschwig C, Lawrence N, Taylor D, Abay E, Njoroge M, Basarab GS, Le Manach C, Paquet T, Cabrera DG, Nchinda AT, de Kock C, Wiesner L, Denti P, Waterson D, Blasco B, Leroy D, Witty MJ, Donini C, Duffy J, Wittlin S, White KL, Charman SA, Jiménez-Díaz MB, Angulo-Barturen I, Herreros E, Gamo FJ, Rochford R, Mancama D, Coetzer TL, van der Watt ME, Reader J, Birkholtz LM, Marsh KC, Solapure SM, Burke JE, McPhail JA, Vanaerschot M, Fidock DA, Fish PV, Siegl P, Smith DA, Wirjanata G, Noviyanti R, Price RN, Marfurt J, Silue KD, Street LJ, Chibale K.

Antimicrob Agents Chemother. 2018 Aug 27;62(9). pii: e00012-18. doi: 10.1128/AAC.00012-18. Print 2018 Sep. Erratum in: Antimicrob Agents Chemother. 2018 Oct 24;62(11):.

PMID:
29941635
22.

Drug permeation and metabolism in Mycobacterium tuberculosis: Prioritising local exposure as essential criterion in new TB drug development.

Tanner L, Denti P, Wiesner L, Warner DF.

IUBMB Life. 2018 Sep;70(9):926-937. doi: 10.1002/iub.1866. Epub 2018 Jun 22. Review.

PMID:
29934964
23.

Tricuspid valve imaging.

Ancona F, Stella S, Capogrosso C, Marini C, Fisicaro A, Margonato A, Denti P, Agricola E.

Minerva Cardioangiol. 2018 Dec;66(6):680-690. doi: 10.23736/S0026-4725.18.04698-4. Epub 2018 Apr 11.

PMID:
29642695
24.

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women.

Schalkwijk S, Ter Heine R, Colbers AC, Huitema ADR, Denti P, Dooley KE, Capparelli E, Best BM, Cressey TR, Greupink R, Russel FGM, Mirochnick M, Burger DM.

Clin Pharmacokinet. 2018 Nov;57(11):1421-1433. doi: 10.1007/s40262-018-0642-9.

25.

Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.

Sekaggya-Wiltshire C, von Braun A, Lamorde M, Ledergerber B, Buzibye A, Henning L, Musaazi J, Gutteck U, Denti P, de Kock M, Jetter A, Byakika-Kibwika P, Eberhard N, Matovu J, Joloba M, Muller D, Manabe YC, Kamya MR, Corti N, Kambugu A, Castelnuovo B, Fehr JS.

Clin Infect Dis. 2018 Aug 16;67(5):708-716. doi: 10.1093/cid/ciy179.

PMID:
29514175
26.

Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated Malaria.

de Kock M, Tarning J, Workman L, Allen EN, Tekete MM, Djimde AA, Bell DJ, Ward SA, Barnes KI, Denti P.

Antimicrob Agents Chemother. 2018 Apr 26;62(5). pii: e01370-17. doi: 10.1128/AAC.01370-17. Print 2018 May.

27.

Optimising mitral repair in functional regurgitation: transcatheter annuloplasty can counteract left ventricle-mitral ring mismatch.

Buzzatti N, Denti P, Alfieri O, La Canna G.

EuroIntervention. 2018 Sep 20;14(7):762-763. doi: 10.4244/EIJ-D-17-01022. No abstract available.

28.

Mitral valve annuloplasty.

Del Forno B, Castiglioni A, Sala A, Geretto A, Giacomini A, Denti P, De Bonis M, Alfieri O.

Multimed Man Cardiothorac Surg. 2017 Oct 6;2017. doi: 10.1510/mmcts.2017.016.

29.

Compare and contrast tricuspid and mitral valve anatomy: interventional perspectives for transcatheter tricuspid valve therapies.

Taramasso M, Pozzoli A, Basso C, Thiene G, Denti P, Kuwata S, Nietlispach F, Alfieri O, Hahn RT, Nickenig G, Schofer J, Leon MB, Reisman M, Maisano F.

EuroIntervention. 2018 Mar 20;13(16):1889-1898. doi: 10.4244/EIJ-D-17-00704.

30.

Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis.

Naidoo A, Ramsuran V, Chirehwa M, Denti P, McIlleron H, Naidoo K, Yende-Zuma N, Singh R, Ngcapu S, Chaudhry M, Pepper MS, Padayatchi N.

Pharmacogenomics. 2018 Jan;19(1):17-29. doi: 10.2217/pgs-2017-0144. Epub 2017 Dec 6.

31.

Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis.

Denti P, Garcia-Prats AJ, Draper HR, Wiesner L, Winckler J, Thee S, Dooley KE, Savic RM, McIlleron HM, Schaaf HS, Hesseling AC.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01521-17. doi: 10.1128/AAC.01521-17. Print 2018 Feb.

32.

Pharmacokinetics and Drug-Drug Interactions of Lopinavir-Ritonavir Administered with First- and Second-Line Antituberculosis Drugs in HIV-Infected Children Treated for Multidrug-Resistant Tuberculosis.

van der Laan LE, Garcia-Prats AJ, Schaaf HS, Tikiso T, Wiesner L, de Kock M, Winckler J, Norman J, McIlleron H, Denti P, Hesseling AC.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e00420-17. doi: 10.1128/AAC.00420-17. Print 2018 Feb.

33.

Beating-Heart Mitral Valve Repair Using a Novel ePTFE Cordal Implantation Device: A Prospective Trial.

Gammie JS, Bartus K, Gackowski A, D'Ambra MN, Szymanski P, Bilewska A, Kusmierczyk M, Kapelak B, Rzucidlo-Resil J, Moat N, Duncan A, Yadev R, Livesey S, Diprose P, Gerosa G, D'Onofrio A, Pitterello D, Denti P, La Canna G, De Bonis M, Alfieri O, Hung J, Kolsut P.

J Am Coll Cardiol. 2018 Jan 2;71(1):25-36. doi: 10.1016/j.jacc.2017.10.062. Epub 2017 Nov 1.

34.

Response to "Lactation Status and Studies of Pyrimethamine Pharmacokinetics in Pregnancy".

de Kock M, Tarning J, Barnes KI, Denti P.

CPT Pharmacometrics Syst Pharmacol. 2017 Nov;6(11):731. doi: 10.1002/psp4.12256. Epub 2017 Oct 20. No abstract available.

35.

Mitral Valve-in-Ring Implantation With a Dedicated Transcatheter Mitral Valve Replacement System.

Cheung A, Denti P, Kiaii B, Bagur R, Webb J, Latib A, Alfieri O.

JACC Cardiovasc Interv. 2017 Oct 9;10(19):2012-2014. doi: 10.1016/j.jcin.2017.08.019. No abstract available.

36.

The International Multicenter TriValve Registry: Which Patients Are Undergoing Transcatheter Tricuspid Repair?

Taramasso M, Hahn RT, Alessandrini H, Latib A, Attinger-Toller A, Braun D, Brochet E, Connelly KA, Denti P, Deuschl F, Englmaier A, Fam N, Frerker C, Hausleiter J, Juliard JM, Kaple R, Kreidel F, Kuck KH, Kuwata S, Ancona M, Malasa M, Nazif T, Nickenig G, Nietlispach F, Pozzoli A, Schäfer U, Schofer J, Schueler R, Tang G, Vahanian A, Webb JG, Yzeiraj E, Maisano F, Leon MB.

JACC Cardiovasc Interv. 2017 Oct 9;10(19):1982-1990. doi: 10.1016/j.jcin.2017.08.011.

37.

Systolic anterior motion after mitral valve repair: a predictive computational model.

Denti P, Pozzoli A, Geretto A, Vicentini L, Di Sanzo S, Monaco F, Crivellari M, Buzzatti N, De Bonis M, La Canna G, Redaelli A, Alfieri O.

Interact Cardiovasc Thorac Surg. 2017 Oct 1;25(4):513-519. doi: 10.1093/icvts/ivx186.

PMID:
28962497
38.

The big parade: emerging percutaneous mitral and tricuspid valve devices.

Natarajan D, Joseph J, Denti P, Redwood S, Prendergast B.

EuroIntervention. 2017 Sep 24;13(AA):AA51-AA59. doi: 10.4244/EIJ-D-17-00571. Review.

39.

Evidence-Based Design of Fixed-Dose Combinations: Principles and Application to Pediatric Anti-Tuberculosis Therapy.

Svensson EM, Yngman G, Denti P, McIlleron H, Kjellsson MC, Karlsson MO.

Clin Pharmacokinet. 2018 May;57(5):591-599. doi: 10.1007/s40262-017-0577-6.

40.

Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant Tuberculosis.

Chirehwa MT, McIlleron H, Rustomjee R, Mthiyane T, Onyebujoh P, Smith P, Denti P.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00490-17. doi: 10.1128/AAC.00490-17. Print 2017 Aug.

41.

Pharmacokinetics of Sulfadoxine and Pyrimethamine for Intermittent Preventive Treatment of Malaria During Pregnancy and After Delivery.

de Kock M, Tarning J, Workman L, Nyunt MM, Adam I, Barnes KI, Denti P.

CPT Pharmacometrics Syst Pharmacol. 2017 Jul;6(7):430-438. doi: 10.1002/psp4.12181. Epub 2017 Jun 9.

42.

Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infants.

McIlleron H, Denti P, Cohn S, Mashabela F, Hoffmann JD, Shembe S, Msandiwa R, Wiesner L, Velaphi S, Lala SG, Chaisson RE, Martinson N, Dooley KE; Tshepiso Study Team.

J Antimicrob Chemother. 2017 Jul 1;72(7):2028-2034. doi: 10.1093/jac/dkx112.

43.

Multimodality imaging of the tricuspid valve with implication for percutaneous repair approaches.

Ancona F, Stella S, Taramasso M, Marini C, Latib A, Denti P, Grigioni F, Enriquez-Sarano M, Alfieri O, Colombo A, Maisano F, Agricola E.

Heart. 2017 Jul;103(14):1073-1081. doi: 10.1136/heartjnl-2016-310939. Epub 2017 Apr 17. Review.

PMID:
28416589
44.

Corrigendum to 'Optimal results immediately after MitraClip therapy or surgical edge-to-edge repair for functional mitral regurgitation: are they really stable at 4 years?' [Eur J Cardiothorac Surg 2016;50:488-494].

De Bonis M, Lapenna E, Buzzatti N, La Canna G, Denti P, Pappalardo F, Schiavi D, Pozzoli A, Cioni M, Di Giannuario G, Alfieri O.

Eur J Cardiothorac Surg. 2017 Apr 1;51(4):807. doi: 10.1093/ejcts/ezx068. No abstract available.

PMID:
28380633
45.

Transcatheter Treatment of Severe Tricuspid Regurgitation With the Edge-to-Edge MitraClip Technique.

Nickenig G, Kowalski M, Hausleiter J, Braun D, Schofer J, Yzeiraj E, Rudolph V, Friedrichs K, Maisano F, Taramasso M, Fam N, Bianchi G, Bedogni F, Denti P, Alfieri O, Latib A, Colombo A, Hammerstingl C, Schueler R.

Circulation. 2017 May 9;135(19):1802-1814. doi: 10.1161/CIRCULATIONAHA.116.024848. Epub 2017 Mar 23.

PMID:
28336788
46.

Percutaneous Tricuspid Valve Annuloplasty Under Conscious Sedation (With Only Fluoroscopic and Intracardiac Echocardiography Monitoring).

Latib A, Mangieri A, Vicentini L, Ferri L, Montorfano M, Ismeno G, Regazzoli D, Ancona MB, Giglio M, Denti P, Colombo A, Agricola E.

JACC Cardiovasc Interv. 2017 Mar 27;10(6):620-621. doi: 10.1016/j.jcin.2016.12.283. No abstract available.

47.

Use of Echocardiography for Guiding Percutaneous Tricuspid Valve Procedures.

Agricola E, Ancona F, Stella S, Rosa I, Marini C, Spartera M, Denti P, Margonato A, Hahn RT, Alfieri O, Colombo A, Latib A.

JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1194-1198. doi: 10.1016/j.jcmg.2016.10.011. Epub 2017 Mar 15. No abstract available.

48.

Does implantation of a single clip provide reliable durability after transcatheter mitral repair?

Buzzatti N, Denti P, La Canna G, Schiavi D, Vicentini L, Scarfò IS, Caso I, De Bonis M, Alfieri O.

Eur J Cardiothorac Surg. 2017 Jul 1;52(1):137-142. doi: 10.1093/ejcts/ezx044.

PMID:
28329199
49.

Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis.

Rockwood N, Pasipanodya JG, Denti P, Sirgel F, Lesosky M, Gumbo T, Meintjes G, McIlleron H, Wilkinson RJ.

Clin Infect Dis. 2017 May 15;64(10):1350-1359. doi: 10.1093/cid/cix158.

50.

Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB.

Naidoo A, Chirehwa M, McIlleron H, Naidoo K, Essack S, Yende-Zuma N, Kimba-Phongi E, Adamson J, Govender K, Padayatchi N, Denti P.

J Antimicrob Chemother. 2017 May 1;72(5):1441-1449. doi: 10.1093/jac/dkx004.

Supplemental Content

Support Center